Philadelphia, PANCT06389994Now EnrollingIRB Ready

Eosinophilic Esophagitis (EoE) Clinical Trial in Philadelphia, PA

Access cutting-edge eosinophilic esophagitis (eoe) treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by Children's Hospital of Philadelphia

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access eosinophilic esophagitis (eoe) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related eosinophilic esophagitis (eoe) treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this eosinophilic esophagitis (eoe) clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Eosinophilic Esophagitis (EoE) Study in Philadelphia

Patients with IgE mediated food Allergy have elevated risk of eosinophilic esophagitis, and new therapies like oral immunotherapy (OIT) carry additional risk of Eosinophilic Esophagitis (EoE). The goal of this study is to investigate the Esophageal String Test (EST) as a screening tool for Eosinophilic Esophagitis (EoE) during OIT therapy. Investigators will compare the efficacy of the Esophageal String Test to symptom assessment using a validated patient reported symptom questionnaire, the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS) v2.0. Investigators will utilize these tools to screen patients at their baseline visit prior to the start of OIT, then at the 3- and 6-month OIT follow-up visits.

Sponsor: Children's Hospital of Philadelphia

Who Can Participate

Inclusion Criteria

An individual must meet all of the following criteria:
Male or female, aged 7 to 18 years old, inclusive
Have a history of Immunoglobulin (IgE)-mediated food allergy
Considering using oral immunotherapy (OIT) for food allergies at CHOP°
Able \& willing to swallow the esophageal capsule
Parental/guardian permission (informed consent) and if appropriate, child assent.
Willing to comply with all study procedures and be available for the duration of the study.

Exclusion Criteria

Known or expected need for MRI imaging during the study period
Known connective tissue disease
Known eosinophilic disorder including any eosinophilic gastrointestinal disorder and hypereosinophilic disorder
Past history of caustic ingestion or other esophageal injury
History of esophageal surgery or dilation (i.e.: tracheoesophageal fistula repair)
History of gastrointestinal motility disorder including esophageal achalasia
History of inflammatory bowel disease
Unwilling or unable to swallow the EST
Oral or intravenous steroids in the preceding 60 days (not including swallowed topical fluticasone, budesonide, etc.)
Participation in a clinical study that may interfere with participation in this study
Pregnant or lactating females
Limited English proficiency
Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT06389994) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Eosinophilic Esophagitis (EoE) Treatment Options in Philadelphia, PA

If you're searching for eosinophilic esophagitis (eoe) treatment options in Philadelphia, PA, this clinical trial (NCT06389994) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced eosinophilic esophagitis (eoe) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all eosinophilic esophagitis (eoe) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Hypertension Trials in Philadelphia, PA

See all pulmonary hypertension clinical trials recruiting in Philadelphia — not just this study.

Browse Pulmonary Hypertension Trials in Philadelphia

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA